Search research articles
Contact Us
Filters
Showing results (21-30 of 149) with videos related to
Page
of 15
Sort By:
Cancer Discovery
|
June 4, 2017
Targeting <i>BRAF</i>-Mutant Colorectal Cancer: Progress in Combination Strategies
Raghav Sundar, David S Hong, Scott Kopetz, et al.
Therapeutic Advances in Medical Oncology
|
March 11, 2015
Nivolumab in NSCLC: latest evidence and clinical potential
Raghav Sundar, Byoung-Chul Cho, Julie R Brahmer, et al.
Frontiers in Medicine
|
April 27, 2017
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
Raghav Sundar, Maxime Chénard-Poirier, Dearbhaile Catherine Collins, et al.
JCO Precision Oncology
|
August 8, 2022
Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies
Jerold Loh, Yvonne Li En Ang, Amit Jain, et al.
Cancer Cell
|
May 21, 2026
Reimagining HER2 therapy: Bridging oncogene addiction and immune modulation
Luke Tillman, Lajos Pusztai, Seth A Wander, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Biomarkers for Homologous Recombination Deficiency in Cancer
Michal M Hoppe, Raghav Sundar, David S P Tan, et al.
Trends in Pharmacological Sciences
|
November 23, 2016
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics
Dearbhaile C Collins, Raghav Sundar, Joline S J Lim, et al.
Cancer Treatment Reviews
|
August 8, 2025
Checkpoint inhibitor benefit in perioperative gastro-esophageal cancer: A meta-analysis of phase III trials
Joseph J Zhao, Kennedy Yao Yi Ng, Raghav Sundar, et al.
Frontiers in Oncology
|
June 6, 2020
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
Raghav Sundar, Elizabeth C Smyth, Siyu Peng, et al.
BMC Cancer
|
November 29, 2019
Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
Mian Wang, Hui Lin Cheng, Violeta Lopez, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 149) with videos related to
Sort By:
Page
of 15
Cancer Discovery
|
June 4, 2017
Targeting <i>BRAF</i>-Mutant Colorectal Cancer: Progress in Combination Strategies
Raghav Sundar, David S Hong, Scott Kopetz, et al.
Therapeutic Advances in Medical Oncology
|
March 11, 2015
Nivolumab in NSCLC: latest evidence and clinical potential
Raghav Sundar, Byoung-Chul Cho, Julie R Brahmer, et al.
Frontiers in Medicine
|
April 27, 2017
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
Raghav Sundar, Maxime Chénard-Poirier, Dearbhaile Catherine Collins, et al.
JCO Precision Oncology
|
August 8, 2022
Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies
Jerold Loh, Yvonne Li En Ang, Amit Jain, et al.
Cancer Cell
|
May 21, 2026
Reimagining HER2 therapy: Bridging oncogene addiction and immune modulation
Luke Tillman, Lajos Pusztai, Seth A Wander, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Biomarkers for Homologous Recombination Deficiency in Cancer
Michal M Hoppe, Raghav Sundar, David S P Tan, et al.
Trends in Pharmacological Sciences
|
November 23, 2016
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics
Dearbhaile C Collins, Raghav Sundar, Joline S J Lim, et al.
Cancer Treatment Reviews
|
August 8, 2025
Checkpoint inhibitor benefit in perioperative gastro-esophageal cancer: A meta-analysis of phase III trials
Joseph J Zhao, Kennedy Yao Yi Ng, Raghav Sundar, et al.
Frontiers in Oncology
|
June 6, 2020
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
Raghav Sundar, Elizabeth C Smyth, Siyu Peng, et al.
BMC Cancer
|
November 29, 2019
Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
Mian Wang, Hui Lin Cheng, Violeta Lopez, et al.
Page
of 15